Get Updates

Press Releases

  1. May 5, 2015

    NPAF Works for Cancer Patients in North Carolina

    Volunteers and staff for the National Patient Advocate Foundation (NPAF) gathered in Raleigh, North Carolina to urge legislators to support oral parity for cancer patients. "Oral chemotherapy products represent the future of cancer treatment.  They are easier to administer, they often have fewer side effects than traditional chemotherapy and they can reduce the number of times that patients need to travel to a doctor's office because they can be taken in the home," said Jason Ranville, NPAF Director of State Government Relations.

    Read More
  2. April 17, 2015

    NPAF Supports Medicare Diabetes Prevention Act

    National Patient Advocate Foundation (NPAF) joined 40 other national organizations today in support of the Medicare Diabetes Prevention Act of 2015, sponsored by Senators Al Franken (D-MN) and Susan Collins (R-ME) and Representative Susan Davis (D-CA). The legislation would provide Medicare coverage for the National Diabetes Prevention Program to individuals at high risk of developing the disease.

    Read More
  3. April 13, 2015

    Advocates applaud the signing of South Dakota oral parity legislation

    Advocates applauded here today as Governor Dennis Daugaard signed into law legislation that will make necessary medical treatments more accessible for cancer patients statewide. SB 101 requires insurance plans that already provide coverage for chemotherapy delivered through an IV to provide comparable coverage for chemotherapy given as a pill. Thirty-seven states plus DC have also enacted similar legislation.

    Read More
  4. April 9, 2015

    The Future of Advocacy

    Tom Hall had exhausted all chemotherapy medicines available and his cancer was spreading.  Without hope, he turned to genetic testing.  FoundationOne, based on his genetic profile, recommended five off-label medicines, which slowed the progression of his disease and gave him more time with his family. A personalized medicine success story?  Absolutely.  However, part of that story is missing: the part where Medicare denied coverage based on his off-label use until ultimately a Patient Advocate Foundation case manager submitted a successful appeal.

    Read More